Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TVB-2640 and Bevacizumab in First Relapse High Grade Astrocytoma
NCT03032484Phase 2Completed
- Sponsor
- UT Health San Antonio
- Start
- May 2017
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of denifanstat in astrocytoma (2 arms), sponsored by UT Health San Antonio. Primary endpoint: Progression Free Survival at 6 Months. Started May 2017; status: completed.
02
Drugs
denifanstat
03
Conditions
astrocytoma
Beyond the preview
Go deeper on NCT03032484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03032484.